Abstract Breast cancer remains one of the most prevalent malignancies among women and is the leading cause of morbidity and mortality. This study was designed to develop and statistically optimized co-loaded tamoxifen (TMX) and letrozole (LTZ) nanostructured lipid carrier coated with hyaluronic acid (HA-TMX-LTZ-NLCs) for synergistic activity towards breast cancer.
Get in touch with Ali
Contact Ali, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack